Legal Battle Looms for Pomdoctor Investors: Class Action Deadline Approaches

Important Reminder for Pomdoctor Investors

As the deadline for a significant securities class action looms, investors in Pomdoctor Limited (NASDAQ: POM) must be aware of their rights and options. Faruqi & Faruqi, LLP, a well-regarded national securities law firm, is currently conducting an investigation into Pomdoctor and its executives regarding potential violations of federal securities laws.

Understanding the Allegations

The firm has noted serious concerns regarding misleading statements and omissions linked to the company’s stock performance. Specifically, it is alleged that Pomdoctor was involved in a fraudulent stock promotion scheme. This scheme allegedly utilized misinformation disseminated via social media and impersonated financial professionals. Furthermore, insiders purportedly engaged in coordinated share dumping during periods of artificial price inflation.

The ensuing chaos led to a drastic decline in stock prices, with Pomdoctor shares dropping from approximately $0.50 on December 10, 2025, to about $0.38 the following day, marking a significant 24% plummet. This drop was influenced by mounting pressure from investors regarding the company's financial viability and overall valuation.

Call to Action for Affected Investors

Investors who acquired Pomdoctor securities between October 9, 2025, and December 11, 2025, are urged to contact Faruqi & Faruqi for consultation. Those affected by this decline can discuss their legal options and the possibility of serving as lead plaintiff in the class action. The lead plaintiff is typically the investor with the most substantial financial interest who leads the case on behalf of other affected shareholders.

If you choose to participate as a lead plaintiff or remain an absent class member, your eligibility to share in any recovery will remain unaffected. This means that the choice to engage actively in the legal process does not influence your potential financial redress from the actions taken against Pomdoctor.

How to Get Involved

Faruqi & Faruqi prominently encourages individuals with relevant information regarding Pomdoctor's practices to contact them, including whistleblowers, former employees, and other shareholders who could provide insights or have experienced related concerns. For further details about the actions being taken against Pomdoctor, investors are directed to visit Faruqi & Faruqi’s dedicated Pomdoctor webpage. Alternatively, direct inquiries can be made by calling partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310).

Conclusion

As the April 6, 2026, deadline draws near, Pomdoctor investors must remain vigilant and informed regarding potential legal recourse. This impending class action could prove vital for those facing losses incurred during this tumultuous period for the company. Staying connected through platforms like LinkedIn or following updates on social media channels will also assist in keeping stakeholders updated with the latest developments. The responsibility lies with investors to advocate for their rights and ensure that justice is pursued in light of these critical allegations.